FR2835745B1 - COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AN HSP INDUCER AND RETINOIDS, METHOD OF TREATMENT AND USE - Google Patents

COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AN HSP INDUCER AND RETINOIDS, METHOD OF TREATMENT AND USE

Info

Publication number
FR2835745B1
FR2835745B1 FR0201746A FR0201746A FR2835745B1 FR 2835745 B1 FR2835745 B1 FR 2835745B1 FR 0201746 A FR0201746 A FR 0201746A FR 0201746 A FR0201746 A FR 0201746A FR 2835745 B1 FR2835745 B1 FR 2835745B1
Authority
FR
France
Prior art keywords
retinoids
cosmetic
treatment
pharmaceutical composition
hsp inducer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0201746A
Other languages
French (fr)
Other versions
FR2835745A1 (en
Inventor
Farra Claude Dal
Nouha Domloge
Dominique Peyronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0201746A priority Critical patent/FR2835745B1/en
Application filed by Vincience SA filed Critical Vincience SA
Priority to AU2003219269A priority patent/AU2003219269A1/en
Priority to PCT/FR2003/000359 priority patent/WO2003066014A1/en
Priority to US10/503,717 priority patent/US20050129779A1/en
Priority to DE60318553T priority patent/DE60318553T2/en
Priority to AT03715073T priority patent/ATE383145T1/en
Priority to EP03715073A priority patent/EP1480610B1/en
Publication of FR2835745A1 publication Critical patent/FR2835745A1/en
Application granted granted Critical
Publication of FR2835745B1 publication Critical patent/FR2835745B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
FR0201746A 2002-02-08 2002-02-13 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AN HSP INDUCER AND RETINOIDS, METHOD OF TREATMENT AND USE Expired - Fee Related FR2835745B1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0201746A FR2835745B1 (en) 2002-02-13 2002-02-13 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AN HSP INDUCER AND RETINOIDS, METHOD OF TREATMENT AND USE
PCT/FR2003/000359 WO2003066014A1 (en) 2002-02-08 2003-02-05 Use of a hsp inducing compound to limit secondary effects of retinoids
US10/503,717 US20050129779A1 (en) 2002-02-08 2003-02-05 Use of a hsp inducing compound to limit the side effects of retinoids
DE60318553T DE60318553T2 (en) 2002-02-08 2003-02-05 USE OF A HSP-INDUCING COMPOUND TO LIMIT SECONDARY EFFECTS OF RETINOIDS
AU2003219269A AU2003219269A1 (en) 2002-02-08 2003-02-05 Use of a hsp inducing compound to limit secondary effects of retinoids
AT03715073T ATE383145T1 (en) 2002-02-08 2003-02-05 USE OF A HSP-INDUCING COMPOUND TO LIMIT SECONDARY EFFECTS OF RETINOIDS
EP03715073A EP1480610B1 (en) 2002-02-08 2003-02-05 Use of a hsp inducing compound to limit secondary effects of retinoids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0201746A FR2835745B1 (en) 2002-02-13 2002-02-13 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AN HSP INDUCER AND RETINOIDS, METHOD OF TREATMENT AND USE

Publications (2)

Publication Number Publication Date
FR2835745A1 FR2835745A1 (en) 2003-08-15
FR2835745B1 true FR2835745B1 (en) 2006-04-28

Family

ID=27620146

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0201746A Expired - Fee Related FR2835745B1 (en) 2002-02-08 2002-02-13 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AN HSP INDUCER AND RETINOIDS, METHOD OF TREATMENT AND USE

Country Status (1)

Country Link
FR (1) FR2835745B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681784B1 (en) * 1991-10-01 1995-06-09 Fabre Pierre Cosmetique DERMATOLOGICAL AND / OR COSMETOLOGICAL COMPOSITION CONTAINING RETINOUIDES AND USE OF NEW RETINOUIDES.
DE19804837A1 (en) * 1998-01-29 1999-08-05 Coty Bv Cosmetic product for regeneration and stimulation of skin cells
FR2809308B1 (en) * 2000-05-29 2003-12-26 Seporga Lab COSMETIC OR DERMO-PHARMACEUTICAL PREPARATIONS CONTAINING HSP AND HSF FROM AN EXTRACT OF MUSHROOMS OR STRESSED YEAST
FR2810241B1 (en) * 2000-06-15 2003-10-17 Seporga Lab COSMETIC OR DERMO-PHARMACEUTICAL PREPARATIONS CONTAINING A ZOOPLANCTON EXTRACT WHICH CONTAINS AND INDUCES HSP

Also Published As

Publication number Publication date
FR2835745A1 (en) 2003-08-15

Similar Documents

Publication Publication Date Title
ATE429922T1 (en) TOPICAL GEL DELIVERY SYSTEMS FOR THE TREATMENT OF SKIN DISEASES
FR2794018B1 (en) ULTRASONIC LOCATION AND TREATMENT APPARATUS
MA27929A1 (en) USE OF CALCITONIN FOR THE TREATMENT OF OSTEOARTHRITIS
DE60109589D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN, CHRONIC PAIN AND / OR NEUROPATHIC PAIN AND MIGRAINE
FR2843125B1 (en) ACTIVE PRINCIPLES STIMULATING HUMAN BETA-DEFENSIVE TYPE 2 AND / OR TYPE 3, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH ACTIVE INGREDIENTS
ATE306481T1 (en) PYRAZOLECARBOXAMIDE USED TO TREAT OBESITY AND OTHER DISEASES
FR2834718B1 (en) COSMETIC AND / OR PHARMACEUTICAL ACTIVE SUBSTANCES
WO2002059604A3 (en) Diagnosis and treatment of multiple sclerosis
IS8071A (en) Method for the treatment of nodular scoliosis, liposuction and related condition types and pharmaceutical compositions
FR2834459B1 (en) MICROBICIDE AGENT AND COSMETIC TREATMENT COMPOSITION CONTAINING THE SAME
DE502004011851D1 (en) Caspase 3, 8, 9 or 10 inhibitors in combination with MEK inhibitors for the treatment of influenza
ATE383877T1 (en) IDENTIFICATION OF SUBSTANCES THAT MODIFY TRANSCRIPTIONAL RESPONSES TO HYPOXIA
FR2841470B1 (en) USE OF ISOFLAVONES FOR THE PREPARATION OF TOPICAL COMPOSITIONS USEFUL FOR PROMOTING SLIMMING AND ASSOCIATED COSMETIC TREATMENT METHOD
YU16399A (en) APPLICATION AND PHARMACEUTICAL FORMULATION FOR SIMULTANEOUS, SEPARATE AND SEQUENTIAL APPLICATION, CONTAINING H +, K+- ATP- aze INHIBITOR AND GLYCOCORTICOID
MA26899A1 (en) PREPARATIONS CONTAINING A GLUCOCORTICOID MEDICAMENT FOR THE TREATMENT OF BRONCHOPULMONARY DISEASES.
DE60127552D1 (en) INTRAKORPORAL MEDICAMENTS FOR HIGH-ENERGETIC PHOTOTHERAPEUTIC TREATMENT OF DISEASES
CR7198A (en) TABLET CONTAINING CETIRIZINE AND PSEUDOEFEDRINE
NO20060781L (en) Use of soluble CD164 in inflammatory and / or autoimmune disorders
FR2835745B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING AN HSP INDUCER AND RETINOIDS, METHOD OF TREATMENT AND USE
FR2830449B1 (en) USE OF TAZAROTENE FOR THE PREPARATION OF A NAIL VARNISH FOR THE TREATMENT AND / OR PREVENTION OF PSORIASIS AND A NAIL VARNISH CONTAINING IT
FR2835746B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING HSP AND RETINOIDS, PROCESSING METHOD AND USE
DE60213234D1 (en) 4- (PENYLPIPERIDIN-4-YLIDENETHYL) BENZAMID DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PAIN, FEAR STORIES OR DISEASES OF THE STOMACH DARM TRAKTS
BR0314139A (en) Substituted 1,4-pyrazine derivatives
DZ3225A1 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF LUNG DISEASES
FR2786100B1 (en) NEW THERAPEUTIC APPLICATION OF NICERGOLIN

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

ST Notification of lapse

Effective date: 20191005